Newsfeeds - Spark Newswire

1 minute read

Baird Initiates Coverage On Oak Street Health with Outperform Rating, Announces Price Target of $60

September 7, 6:06 AM

Baird analyst Vikram Kesavabhotla initiates coverage on Oak Street Health (NYSE:OSH) with a Outperform rating and announces Price Target of $60.

OSH

1 minute read

Morgan Stanley Maintains Overweight on Oak Street Health, Lowers Price Target to $60

By Benzinga Newsdesk

August 31, 7:46 AM

Morgan Stanley analyst Craig Hettenbach maintains Oak Street Health (NYSE:OSH) with a Overweight and lowers the price target from $79 to $60.

OSH

12 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 12, 2021

By Benzinga Insights

August 12, 10:04 AM

ACHC

1 minute read

Raymond James Maintains Outperform on Oak Street Health, Lowers Price Target to $60

By Benzinga Newsdesk

August 12, 7:40 AM

Raymond James analyst John Ransom maintains Oak Street Health (NYSE:OSH) with a Outperform and lowers the price target from $70 to $60.

OSH

1 minute read

Barclays Initiates Coverage On Oak Street Health with Overweight Rating, Announces Price Target of $71

By Benzinga Newsdesk

August 12, 5:13 AM

Barclays analyst Sarah James initiates coverage on Oak Street Health (NYSE:OSH) with a Overweight rating and announces Price Target of $71.

OSH

7 minute read

85 Biggest Movers From Yesterday

By Lisa Levin

August 11, 5:14 AM

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.

ABVC

4 minute read

54 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

August 10, 12:02 PM

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.

ACI

1 minute read

Earnings

Oak Street Health: Q2 Earnings Insights

By Benzinga Insights

August 9, 5:38 PM

Shares of Oak Street Health (NYSE:OSH) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 99.39% year over year to ($0.44), which missed the estimate of ($0.34).

OSH

1 minute read

Oak Street Health Q2 EPS $(0.44) Misses $(0.34) Estimate, Sales $353.10M Beat $318.00M Estimate

By Benzinga Newsdesk

August 9, 5:24 PM

Oak Street Health (NYSE:OSH) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.34) by 29.41 percent. This is a 99.39 percent increase over losses of $(72.53) per share from

OSH

14 minute read

Earnings Scheduled For August 9, 2021

By Benzinga Insights

August 9, 4:11 AM

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.

ACM